Dan Theodorescu
Affiliations: | University of Virginia, Charlottesville, VA |
Area:
Oncology, Pathology, Molecular BiologyGoogle:
"Dan Theodorescu"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Abdel-Hafiz HA, Kailasam Mani SK, Huang W, et al. (2023) Single-cell profiling of murine bladder cancer identifies sex-specific transcriptional signatures with prognostic relevance. Iscience. 26: 107703 |
| Abdel-Hafiz HA, Schafer JM, Chen X, et al. (2023) Y chromosome loss in cancer drives growth by evasion of adaptive immunity. Nature |
| Castaneda PR, Theodorescu D, Rosser CJ, et al. (2023) Identifying novel biomarkers associated with bladder cancer treatment outcomes. Frontiers in Oncology. 13: 1114203 |
| Bhowmick N, Posadas E, Ellis L, et al. (2023) Targeting Glutamine Metabolism in Prostate Cancer. Frontiers in Bioscience (Elite Edition). 15: 2 |
| Agarwal N, Zhou Q, Arya D, et al. (2022) AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder Cancer. International Journal of Molecular Sciences. 23 |
| Schafer JM, Xiao T, Kwon H, et al. (2022) Sex-biased adaptive immune regulation in cancer development and therapy. Iscience. 25: 104717 |
| Lee YC, Lam HM, Rosser C, et al. (2022) The dynamic roles of the bladder tumour microenvironment. Nature Reviews. Urology |
| Zhang Y, Huo F, Cao Q, et al. (2022) FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer. Journal For Immunotherapy of Cancer. 10 |
| Nikolos F, Hayashi K, Hoi XP, et al. (2022) Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors. Nature Communications. 13: 1487 |
| Wang Y, Zhang Y, Li PC, et al. (2022) Development of novel aptamer-based targeted chemotherapy for bladder cancer. Cancer Research |